406-407 / 2063
ESTRO BCR Course / Pathogenesis of NT effects – W. Dörr
Inzidence of late effects, general [%]
0
10
20
30
40
50
neg.
pos.
early response
p<0.01
3/55
30/104
Weiss et al., Radiother. Oncol. 53, 1999, 37-44
Endometrium-Ca I+II,
adjuvant radiotherapy
n=159
Consequential late effects (CLE): Examples